Answers are grounded in this paper and cite their sources.
In the final results of a randomized trial involving patients with HIV infection, pitavastatin reduced the incidence of adverse cardiovascular events at 5.6 years of follow-up as compared with placebo.
No takes yet. Share an insight, caveat, or question.
Grinspoon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: